Purchase Order 140G0324P0329
- Not listed
- This is a firm fixed-price purchase order awarded by the Office of Acquisitions and Grants, a civilian agency, to Illumina, Inc., a manufacturer of genomic sequencing instruments and solutions. The contract is for $71,643.00 to provide service maintenance for an Illumina MiSeq sequencer. The award has no set-aside designation and the period of performance runs through June 10, 2024. Illumina has a history of providing sequencing systems and related services to various government agencies,...
- Illumina, Inc. was awarded a firm fixed-price purchase order valued at $15,470.75 for a DNA Sequencer MiSeq Comprehensive Plan annual service contract with quarterly payments. The contract, which was awarded on May 6, 2016, with an ultimate completion date of May 9, 2017, covers product care and maintenance services for the MiSeq sequencing instrument. The place of performance is located in San Diego, California, and the contract was funded by a civilian federal agency within the Midwest Area....
- Illumina, Inc. was awarded a $78,115 firm fixed-price purchase order by the Office of Acquisitions and Grants on January 12, 2023, for maintenance support services on a MiSeq M06789 sequencing instrument. The contract establishes a base period plus four option years, with an ultimate completion date of February 22, 2028. The award includes an estimated annual uplift of 4% applied at each option year exercise, with pricing adjusted downward if manufacturer list prices decrease below quoted...
- Illumina, Inc., a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, was awarded a delivery order valued at $15,349.28 for MiSeq Silver Support Plan maintenance services on a MiSeq sequencing instrument (serial number M01098) located in Ames, Iowa. The contract, awarded on December 16, 2025, carries a firm fixed price structure with an ultimate completion date of December 15, 2026. This delivery order does not utilize a set-aside designation,...
- This is a firm fixed-price delivery order awarded by the Animal and Plant Health Inspection Service, a civilian agency within the U.S. Department of Agriculture, to Illumina, Inc., a manufacturer of sequencing and analytical instruments and reagents. The $14,562.62 award is for the renewal of a service contract to provide maintenance and support for Illumina's MiSeq sequencing equipment. The order has a period of performance through July 29, 2024 and does not include any set-aside...
- Illumina, Inc. was awarded a firm fixed-price delivery order valued at $13,484.57 for an Illumina MiSeq Silver Support Plan, with performance at Fort Pierce, Florida. The delivery order, issued on May 2, 2022, with an ultimate completion date of May 2, 2023, represents a maintenance and support service agreement for the company's MiSeq sequencing instrument platform. This award was issued by a Southeast Area civilian federal agency and carries no set-aside designation, reflecting Illumina's...
- Illumina, Inc. was awarded a $4,800 firm fixed price purchase order (CAT# SP-103-1004) for Product Care MiSeq Preventative maintenance services, with an ultimate completion date of August 31, 2019. The contract was awarded on August 28, 2018, with no set-aside designation applied. The place of performance is located in San Diego, California, where Illumina maintains its headquarters. Funding was provided by a civilian federal agency within the Midwest Area. This purchase order represents a...
- Illumina, Inc. was awarded a firm fixed-price Blanket Purchase Agreement (BPA) call valued at $4,050 for maintenance and recertification services on a MiSeq System sequencing instrument. The contract, issued on March 27, 2017, with completion targeted for April 30, 2017, encompasses preventive maintenance labor, travel expenses, replacement parts included in the preventive maintenance kit, and system recertification following equipment relocation. The work is to be performed in Albany,...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract, valued at $89,573.00, is for preventative maintenance and repair services for the agency's MiSeq sequencing system. The contract has an ultimate completion date of April 30, 2028 and does not include any set-aside designation. Illumina has previously provided a range of sequencing instruments, reagents, and...
- Illumina, Inc. was awarded a firm fixed-price contract valued at $10,720.61 for maintenance services on a MiSeq DNA sequencer at a civilian federal facility in Peoria, Illinois. The contract was issued on January 19, 2016, as a Blanket Purchase Agreement (BPA) call with a period of performance from January 17, 2016, through September 30, 2016. No set-aside designation was applied to this award, reflecting Illumina's specialized technological capabilities in genomic sequencing equipment...
Illumina, Inc. has been awarded a purchase order valued at $89,930.78 for annual MiSeq support and maintenance services, with an ultimate completion date of October 27, 2029. The contract, awarded on August 12, 2024, by the Office of Acquisitions and Grants, utilizes firm fixed pricing with no set-aside designation. Performance will take place in Honolulu, Hawaii. The MiSeq is a mid-throughput genomic sequencing instrument widely used in research and diagnostic applications, and this contract provides essential annual maintenance and support services to ensure continued operational capability of the government's sequencing infrastructure. This award represents Illumina's continued engagement with federal civilian agencies for genomic sequencing technology support. Illumina, a biotechnology company headquartered in San Diego, California, specializes in DNA and RNA sequencing platforms and related services. The company maintains multiple contract relationships across federal agencies including the National Institutes of Health, Centers for Disease Control and Prevention, Department of Agriculture, and other civilian and defense organizations. This particular purchase order is consistent with Illumina's established market position as a specialized provider of genomic sequencing technologies and maintenance services to federal laboratory facilities.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Exercise an Option | $17.4k | 12/4/25 | |
| Not listed | Not listed | $16.2k | 8/12/24 |